TrialEuropean journal of cancer (Oxford, England : 1990)2021

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial.

Somnath Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.